Cost-Effectiveness Analysis of CCTA in SUS, as Compared to Other Non-Invasive Imaging Modalities in Suspected Obstructive CAD.
Patricia Bastos do CarmoCarlos Alberto da Silva MaglianoHelena Cramer Veiga ReyGabriel Cordeiro CamargoLuís Filipe Lannes TrocadoIlan GottliebPublished in: Arquivos brasileiros de cardiologia (2022)
Using current concepts of health technology assessment, this study provides a ranking for decision-making concerning which diagnostic strategy to use in a population with an intermediate pre-test risk for CAD. With a feasible cost estimate adopted for CTA, the impact of including this to the list of the diagnostic arsenal would represent a cost-effective strategy in most of the evaluated scenarios with broad variations in the willingness to pay.